Who has been buying curacle stock?

3 distinct insiders have filed 3 disclosed insider purchases in curacle (365270), most recently on 2026-06-08. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does curacle have?

curacle has 3 buy-side and 1 sell-side disclosures on record, covering ₩1.4B ($962K) in total reported value, spanning 2024-03-11 to 2026-06-08.

Where does StockDrifts get curacle insider data?

From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

curacle 365270

Company

큐라클curacle

Insiders

Buys

Total Value

₩1.4B ($962K)

Avg Return

+34.27%

Last Filing

2026-06-08

curacle (365270) has 3 disclosed insider purchases and 1 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩1.4B ($962K) in reported transaction value. The earliest filing StockDrifts holds for curacle is dated 2024-03-11; the most recent is 2026-06-08. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +34.27%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-06-08	BUY	PROGRAM	김정한 Kim Jeong-han	Managing Director	8.0K	₩11,000	+22.7%	₩88M ($61K)
2026-06-08	BUY	PROGRAM	이원일 Wonil Lee	Managing Director	5.0K	₩11,000	+22.7%	₩55M ($38K)
2026-06-08	BUY	PROGRAM	표정인 facial expression	moving	20.0K	₩11,000	+22.7%	₩220M ($153K)
2026-06-08	BUY	PROGRAM	추연성 inference	Other non-executive directors	10.0K	₩11,000	+22.7%	₩110M ($76K)
2026-06-08	BUY	PROGRAM	황용 Hwang Yong	moving	4.0K	₩11,000	+22.7%	₩44M ($31K)
2026-06-08	BUY	PROGRAM	최재진 Jaejin Choi	Managing Director	8.0K	₩11,000	+22.7%	₩88M ($61K)
2025-09-24	BUY	Market Buy	최동훈 Choi Dong-hoon	Outside Director	600	₩6,380	+153.6%	₩4M ($3K)
2025-09-22	BUY	Market Buy	최동훈 Choi Dong-hoon	Outside Director	2.0K	₩6,030	+168.3%	₩12M ($8K)
2025-09-11	BUY	유상신주취득	권영근 Younggeun Kwon	Chairman of the Board	271.2K	₩7,330	+120.7%	₩2.0B ($1.4M)
2025-09-11	SELL	기타	권영근 Younggeun Kwon	Chairman of the Board	-271.2K	₩7,330	-120.7%	₩2.0B ($1.4M)
2025-09-11	BUY	유상신주취득	황용 Hwang Yong	moving	10.0K	₩7,330	+120.7%	₩73M ($51K)
2025-09-11	SELL	기타	황용 Hwang Yong	moving	-9.0K	₩7,330	-120.7%	₩66M ($46K)
2025-07-24	SELL	장외매도	권영근 Younggeun Kwon	Chairman of the Board	-632.8K	₩5,070	-219.1%	₩3.2B ($2.2M)
2025-07-24	SELL	Market Sell	권영근 Younggeun Kwon	Chairman of the Board	-270.0K	₩5,070	-219.1%	₩1.4B ($951K)
2025-07-18	BUY	기타	황용 Hwang Yong	moving	9.0K	₩5,450	+196.9%	₩49M ($34K)
2025-07-18	BUY	기타	김영명 Youngmyeong Kim	Other non-executive directors	20.0K	₩5,450	+196.9%	₩109M ($76K)
2025-07-18	BUY	기타	권영근 Younggeun Kwon	Chairman of the Board	903.9K	₩5,450	+196.9%	₩4.9B ($3.4M)
2024-04-30	SELL	시간외매매	이인규 Lee In-gyu	-	-442.5K	₩15,694	-3.1%	₩6.9B ($4.8M)
2024-03-11	BUY	PROGRAM	김정한 Kim Jeong-han	Managing Director	608	-	-	-

Frequently asked questions

Who has been buying curacle stock?: 3 distinct insiders have filed 3 disclosed insider purchases in curacle (365270), most recently on 2026-06-08. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does curacle have?: curacle has 3 buy-side and 1 sell-side disclosures on record, covering ₩1.4B ($962K) in total reported value, spanning 2024-03-11 to 2026-06-08.
Where does StockDrifts get curacle insider data?: From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for curacle. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.